Abivax (AAVXF) Current Taxes (2021 - 2025)
Abivax (AAVXF) posted Current Taxes of $4.9 million for Q3 2025, down 82.21% on a QoQ basis from $27.4 million in Q2 2025.
Analysis
Abivax (AAVXF) Current Taxes (2021 - 2025) Analysis & Trends
Abivax has reported Current Taxes for 5 years, with the latest figure at $4.9 million in Q3 2025.
- On a quarterly basis, Current Taxes changed N/A year-over-year to $4.9 million in Q3 2025; TTM through Sep 2025 was $4.9 million, a N/A change from a year earlier, with the FY2024 full-year figure at $23.1 million, down 27.62% from the prior year.
- Current Taxes was $4.9 million for Q3 2025 at Abivax, down from $27.4 million in the prior quarter.
- The five-year high for Current Taxes was $31.9 million in Q4 2023, with the low at $714981.8 in Q4 2021.
- Average Current Taxes over 5 years is $19.5 million, with a median of $22.2 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: Current Taxes soared 2747.78% in 2022, then dropped 27.62% in 2024.
- Over 5 years, Current Taxes stood at $714981.8 in 2021, then jumped by 2747.78% to $20.4 million in 2022, then surged by 56.44% to $31.9 million in 2023, then decreased by 27.62% to $23.1 million in 2024, then slumped by 78.85% to $4.9 million in 2025.
- The last three Current Taxes figures came in at $4.9 million (Q3 2025), $27.4 million (Q2 2025), and $21.3 million (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.37 Bn | 197.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.12 Bn | 177.94 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.11 Bn | 124.26 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.69 Bn | 56.50 Bn | 1.37 Bn | 49.00 Mn |
| 6 | Moderna | 54.62 Bn | 49.48 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.14 Bn | 30.84 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn | 86.90 Mn |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn | 74.18 Mn |
| 10 | Abivax | 10.92 Bn | 10.92 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 4.87 Mn |
| Jun 30, 2025 | 27.40 Mn |
| Mar 31, 2025 | 21.32 Mn |
| Dec 31, 2024 | 23.05 Mn |
| Jun 30, 2024 | 26.72 Mn |
| Dec 31, 2023 | 31.85 Mn |
| Dec 31, 2022 | 20.36 Mn |
| Dec 31, 2021 | 714,981.84 |